ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
CP000083 |
|
284461-73-0 |
Sorafenib tosylate - |
0 | C21H16CLF3N4O3 | |
CP007095 |
|
5398-77-6 |
4-(Methylsulfonyl)benzaldehyde - 96% |
0 | C8H8O3S | |
CP002319 |
|
2611-61-2 |
2-[(dichloroacetyl)amino]-3-hydroxy-3-[4-(methylsulphonyl)phenyl]propyl [R-(R*,R*)]aminoacetate monohydrochloride - 99% |
0 | C14H18CL2N2O6S.HCL;C14H19 | |
CP003203 |
|
138-14-7 |
Deferoxamine mesylate - 98% |
0 | C25H48N6O8.CH4O3S | |
CP003863 |
|
181630-15-9 |
Picoplatin - 98% |
0 | C6H7N.PTCL2.NH3 | |
CP008164 |
|
124-41-4 |
N/A - 99% |
0 | CH3NAO | |
CP002162 |
|
67-56-1 |
Methyl alcohol - |
0 | CH3OH;CH4O | |
CP007651 |
|
720720-96-7 |
4,5,6,7-TETRAHYDRO-1H-IMIDAZOL[4,5-C]-PYRIDINE DIHYDROCHLORIDE - 98% |
0 | C8H10N2O2S.HCL | |
CP006536 |
|
127045-41-4 |
Pazufloxacin - 99% |
0 | C16H15N2O4F | |
CP000117 |
|
176760-98-8 |
(S)-10-(Cyanomethyl)-9-fluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid - 98% |
0 | C15H11N2O4F | |
CP005111 |
|
1210348-34-7 |
- 99% |
0 | C14H27N3O3.C2H2O4 | |
CP001437 |
|
82956-11-4 |
Nafamostat mesylate - 99% |
0 | C19H17N5O2.2(CH4O3S);C21H25N5O8S2 | |
CP006893 |
|
417716-92-8 |
4-[3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide - 98% |
0 | C21H19N4O4CL | |
CP002918 |
|
223652-90-2 |
Garenoxacin mesylate hydrate - 99% |
0 | C23H20N2O4F2.CH4O3S.H2O | |
CP005710 |
|
23564-05-8 |
Thiophanate-Methyl - ≥95% |
0 | C12H14N4O4S2 | |
CP003187 |
|
3144-09-0 |
Methylsulfonamide - 99% |
0 | CH5NO2S | |
CP001391 |
|
56974-61-9 |
gabexate mesylate - 98.5% |
0 | C16H23N3O4.CH4O3S | |
CP005543 |
|
7143-01-3 |
Methanesulfonic anhydride - 98% |
0 | C2H6O5S2 | |
CP003170 |
|
75-75-2 |
Methanesulfonic acid - 99% |
0 | CH4O3S | |
CP003957 |
|
210353-53-0 |
Gemifioxacin mesylate - 99% |
0 | C18H20FN5O4.CH4SO3 | |